SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-001855
Filing Date
2021-01-07
Accepted
2021-01-07 08:22:47
Documents
2
Period of Report
2021-01-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm211925d1_6k.htm 6-K 9813
2 EXHIBIT 99.1 tm211925d1_ex99-1.htm EX-99.1 16341
  Complete submission text file 0001104659-21-001855.txt   27185
Mailing Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK
Business Address ZERNIKEDREEF 9 LEIDEN P7 2333 CK 31 88 166 7000
ProQR Therapeutics N.V. (Filer) CIK: 0001612940 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36622 | Film No.: 21513046
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences